Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Mantle-Cell 2Dendritic Cell Sarcoma, Interdigitating 2Recurrence 1Lymphoma, B-Cell 1Lymphoma 1Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

polatuzumab vedotin 2glofitamab 2Prednisone 2Doxorubicin 2Cyclophosphamide 2relmacabtagene autoleucel 1obinutuzumab 1axicabtagene ciloleucel 1Rituximab 1Oxaliplatin 1Gemcitabine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Dendritic Cell Sarcoma, Interdigitating × glofitamab × Clear all
NCT07326371 2026-01-08

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Ruijin Hospital

Phase 2 Not yet recruiting
24 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

NCT07231250 2025-11-19

Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

Sun Yat-sen University

Phase 2 Not yet recruiting
40 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡